Company
Legend Biotech Corporation
NASDAQ:LEGN
Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of cutting-edge therapeutics for patients worldwide.
2 stories
Legend Biotech set for clinical development of potential treatment for small cell lung cancer after FDA approval
It means the clinical development can now proceed on LB2102, an investigational, antigen receptor T-cell (CAR-T) therapy